Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.26
-6.04 (-2.62%)
AAPL  271.08
+1.38 (0.51%)
AMD  258.64
-5.69 (-2.15%)
BAC  53.12
+0.54 (1.02%)
GOOG  283.62
+8.45 (3.07%)
META  667.60
-84.07 (-11.18%)
MSFT  523.02
-18.53 (-3.42%)
NVDA  202.50
-4.54 (-2.19%)
ORCL  259.69
-15.61 (-5.67%)
TSLA  442.10
-19.41 (-4.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.